MMP9 and cancer: MEL also specifically inhibits matrix metalloproteinase-9 (MMP-9) production, which is crucial for cancer cell motility (Jo et al., 2012; Vago et al., 2016), by downregulating activator protein-1 (AP-1) and NF-B expression (Pike et al., 1999; Moon et al., 2006).